NCT01423123 Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer Status COMPLETED Phase PHASE1
NCT01422187 A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease Status COMPLETED Phase PHASE3
NCT01421589 Growth Hormone Treatment on Phosphocreatine Recovery in Obesity Status COMPLETED Phase NA
NCT01421303 Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel. Status COMPLETED Phase N/A
NCT01421069 Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis Status COMPLETED Phase PHASE3
NCT01421043 A Study to Determine Whether an Oral Drops Formulation of Triazolam is Bioequivalent to a Tablet Formulation in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01420081 A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer Status TERMINATED Phase PHASE2
NCT01419041 A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function Status COMPLETED Phase PHASE1
NCT01416194 Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU) Status COMPLETED Phase N/A
NCT01416025 A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing Status COMPLETED Phase PHASE4
NCT01415102 A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372. Status COMPLETED Phase PHASE1
NCT01414257 Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan) Status COMPLETED Phase N/A
NCT01411228 A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease Status COMPLETED Phase PHASE3
NCT01411215 A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department Status TERMINATED Phase N/A
NCT01408355 A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose. Status COMPLETED Phase PHASE1
NCT01407016 A Study To Assess The Safety, Tolerability And Pharmacokinetics Of Metronidazole Injection In Healthy Japanese Subjects Status COMPLETED Phase PHASE1
NCT01405196 Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT01405170 A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions Status WITHDRAWN Phase PHASE1
NCT01405157 A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions Status WITHDRAWN Phase PHASE1